BEB Holdings, LLC 4
Research Summary
AI-generated summary
Turn Therapeutics (TTRX) CEO Bradley E. Burnam Gifts 600,000 Shares
What Happened
Bradley E. Burnam, CEO of Turn Therapeutics (TTRX), reported gifts of a total of 600,000 common shares on May 28, 2026 — two separate gifts of 300,000 shares each. Each gift was reported at $0.00 per share (transaction code G) and therefore shows no cash proceeds or purchase price. The filings identify the recipients as revocable trusts for his daughter and son.
Key Details
- Transaction date: May 28, 2026. Form 4 filed June 1, 2026 (timely — within the two-business-day filing window).
- Reported price: $0.00 per share; reported total proceeds/value: $0.00.
- Shares transferred: 2 × 300,000 = 600,000 shares gifted.
- Shares owned after transaction: Not specified in the provided Form 4 excerpt. Footnote notes BEB Holdings, LLC holds shares and the reporting person is sole member with voting/dispositive power (see below).
- Relevant footnotes:
- F1: Some holdings are held by BEB Holdings, LLC; Burnam is sole member and may be deemed beneficial owner of those LLC-held shares.
- F2/F3: The 300,000-share gifts were to the Bradley E. Burnam 2026 Revocable Trust FBO Gabriella G. Burnam (daughter) and the Bradley E. Burnam 2026 Revocable Trust FBO Luca M. Burnam (son). Burnam disclaims beneficial ownership of the securities held by those trusts.
Context
Gifts are non-market transfers and generally do not signal insider sentiment about the stock price the way open-market purchases or sales might. The Form 4 here documents gift transactions (code G), not sales or option exercises, and thus no cash changed hands in these reported entries.